Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.42.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.42.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HN.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HN.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HN.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HN.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HN.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.7.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.7.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.7.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
DV.7.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DV.7.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DV.7.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DV.7.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.7.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.20.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.20.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.20.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.20.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.20.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.20.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.20.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.20.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.5.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.5.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.5.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.5.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.5.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.5.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.5.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.5.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.3.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.3.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.3.12EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.3.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.3.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GN.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GN.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GN.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GN.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GN.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GN.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used